Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi, Pilar Alcaide, Folkert W. Asselbergs, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 336-356
Open Access | Times Cited: 122
Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro
Yuan-Chieh Yeh, Ly Hien Doan, Zi-Yi Huang, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 59
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity
Nikaïa Smith, Céline Possémé, Vincent Bondet, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19
Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez‐Galán, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Immune Mechanisms of Plaque Instability
Teresa Gerhardt, Arash Haghikia, Philip Stapmanns, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 37
Innate immunity and interferon in SARS-CoV-2 infection outcome
Ram Savan, Michael Gale
Immunity (2023) Vol. 56, Iss. 7, pp. 1443-1450
Open Access | Times Cited: 25
COVID19 biomarkers: What did we learn from systematic reviews?
Sabina Semiz
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 Cohort
Sara Taleb, Nisha Stephan, Sareena Chennakkandathil, et al.
PROTEOMICS (2025)
Closed Access
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1724-1724
Open Access | Times Cited: 11
Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic
Yuting Sun, Bin Luo, Yueping Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Paradigm of immune dysregulation in coronavirus disease-2019 infection
Om Saswat Sahoo, Karthikeyan Pethusamy, Arnab Nayek, et al.
Exploration of Immunology (2024), pp. 1-33
Open Access | Times Cited: 3
SLE serum induces altered goblet cell differentiation and leakiness in human intestinal organoids
Inga Viktoria Hensel, Szabolcs Éliás, Michelle Steinhauer, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 547-574
Open Access | Times Cited: 3
Type I interferon pathway genetic variants in severe COVID-19
Artur Fontenelle Lima Montenegro, Marco Clementino, Juliana Navarro Ueda Yaochite
Virus Research (2024) Vol. 342, pp. 199339-199339
Open Access | Times Cited: 3
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Dóra Bencze, Tünde Fekete, Kitti Pázmándi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10968-10968
Open Access | Times Cited: 16
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients
Zahra Sefatjoo, Seyed Reza Mohebbi, Seyed Masoud Hosseini, et al.
Cytokine (2024) Vol. 175, pp. 156495-156495
Closed Access | Times Cited: 2
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019
Hossein Khorramdelazad, Mohammad Hossein Kazemi, Maryam Azimi, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175051-175051
Open Access | Times Cited: 12
COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Nikoo Saeedi, Narjes Sadat Farizani Gohari, AmirAli Moodi Ghalibaf, et al.
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 547-553
Closed Access | Times Cited: 7
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 7
New‐onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection
Roy Anindya, Guy A. Rutter, Gargi Meur
Immunology and Cell Biology (2022) Vol. 101, Iss. 3, pp. 191-203
Open Access | Times Cited: 11
Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
Vasiliki Georgakopoulou, Peter Lembessis, Charalampos Skarlis, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
(2023)
Open Access | Times Cited: 5
Airway Epithelial-Derived Immune Mediators in COVID-19
Tony J. F. Guo, Gurpreet K. Singhera, Janice M. Leung, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1655-1655
Open Access | Times Cited: 5
Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma
Pornpitra Pratedrat, Duangnapa Intharasongkroh, Jira Chansaenroj, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 112-112
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top